Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tryptorelin for Luteal Support in IUI
NCT00503217Phase 4Completed
- Sponsor
- IVI
- Start
- Feb 2005
- Primary completion
- Dec 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triptorelin in infertility (2 arms), sponsored by IVI. Primary endpoint: Clinical Pregnancy Rate at 4 weeks. Started Feb 2005; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00503217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503217.